Covered recipient · General Payments record
LAUREN A AMY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,478.29
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $977.79 | 52 |
| Education | $81.99 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $136.32 | 5 |
| PFIZER INC. | $134.53 | 9 |
| Merck Sharp & Dohme Corporation | $82.56 | 4 |
| Acerta Pharma LLC | $82.22 | 4 |
| JAZZ PHARMACEUTICALS INC. | $54.62 | 2 |
| Celgene Corporation | $49.78 | 3 |
| GlaxoSmithKline, LLC. | $43.79 | 2 |
| SOBI, INC | $40.79 | 2 |
| Incyte Corporation | $36.45 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.07 | 2 |
| Gilead Sciences, Inc. | $33.67 | 2 |
| AVEO Pharmaceuticals, Inc. | $32.48 | 1 |
| Octapharma USA, Inc. | $31.36 | 1 |
| TerSera Therapeutics LLC | $30.45 | 2 |
| Lilly USA, LLC | $25.73 | 1 |
| Janssen Pharmaceuticals, Inc | $22.00 | 1 |
| Blueprint Medicines Corporation | $21.80 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.82 | 1 |
| Genentech USA, Inc. | $19.22 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.81 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.56 | 1 |
| ARRAY BIOPHARMA INC | $17.04 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.44 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.52 | 1 |
| Astellas Pharma US Inc | $15.29 | 1 |
| Daiichi Sankyo Inc. | $14.15 | 1 |
| Myriad Genetic Laboratories, Inc. | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.